13 March 2022 in Psychogeriatrics
7 December 2020 in Alzheimer's & Dementia
Background: It has recently been reported that pathological molecules of Alzheimer’s disease (AD), such as tau, are transmitted through extracellular vesicles (EVs). We hypothesized that AD‐related proteins are detectable in neuron‐derived EVs (NDE) present in peripheral blood, since the pathological proteins will be protected by the lipid bilayer of EVs from degradation. The objective of the study is to assess the novel NDE isolation method for the quantification of AD‐related proteins using ultra‐sensitive digital ELISA method.Method: Blood‐derived EVs were first isolated from control and AD patients, and the degradation efficiency of AD‐related proteins in the blood and EVs was assessed by protease treatment in vitro. The remaining AD‐related molecules were quantified by Simoa HD‐1 Analyzer. The amount of protease‐resistant AD‐related proteins in the blood‐derived EVs was compared between healthy control subjects and AD patients. Next, NDE was affinity‐purified from peripheral blood‐derived EVs and conditioned medium of iPS‐derived neurons/astrocyte using novel antibodies specific to neuron‐specific membrane protein X (MPX). The purification efficiency was assessed by quantification of neuronal markers present in the isolated NDE.Result: Protease treatment of human plasma degraded more than 99% of Aβ40 and Aβ42 present in the blood. On the other hand, around 5% of tau in the blood was protease‐resistant implied that the 5% of tau in blood might be protected from proteases by the EV structure. Actually, in blood‐derived EV fraction, more than 50% of tau was protease resistant, although Aβ40 and Aβ42 were hardly detectable after protease treatment, indicated that 50% of EV‐associated tau was compartmentalized inside of the EV. Furthermore, we succeeded in efficient separation of NDE from blood‐derived EV fraction using anti‐MPX antibody.Conclusion: The present study revealed the difference in the amount of protease‐resistant Aβ40, Aβ42 and tau in the blood, which are more enriched in blood‐derived EVs. This phenomenon may be strongly involved in the transmission of AD pathological proteins through EVs. In addition, the novel NDE isolation method may be highly beneficial for the future development of NDE biomarkers.